References

1. Lloyd KM II, Dennis M. Cowden's disease. A possible new symptom complex with multiple system involvement. Ann Intern Med 1963; 58:136-142.

2. Hildenbrand C, Burgdorf WH, Lautenschlager S. Cowden syndrome—diagnostic skin signs. Dermatology 2001; 202(4):362-366.

3. Eng C. Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet 2000; 37(11):828-830.

4. Nelen MR, Padberg GW, Peeters EA, et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 1996; 13(1):114-116.

5. Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg 1967; 54(3):191—195.

6. Torre D. Multiple sebaceous tumors. Arch Dermatol 1968; 98(5):549-551.

7. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995; 33(1):90-104.

8. Schreibman IR, Baker M, Amos C, et al. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 2005; 100(2):476-490.

9. Marignani PA. LKB1, the multitasking tumour suppressor kinase. J Clin Pathol 2005 ; 58(1): 15-19.

10. Pau H, Carney AS, Murty GE. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): otorhinolaryngological manifestations. Clin Otolaryngol Allied Sci 2001; 26(2): 93-98.

11. Bayrak-Toydemir P, Mao R, Lewin S, et al. Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians. Genet Med 2004; 6(4): 175-191.

12. Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129(1): 92-96.

13. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001; 137(3):357-364.

14. Leaute-Labreze C, Lamireau T, Chawki D, et al. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 2000; 83(4):347-352.

15. http://www.who.int/lep/ (accessed September 2005).

16. Ramos-e-Silva M, Rebello PF. Leprosy. Recognition and treatment. Am J Clin Dermatol 2001; 2 (4):203-211.

17. Ramos-E-Silva M, Oliveira ML, Munhoz-da-Fontoura GH. Leprosy: uncommon presentations. Clin Dermatol 2005; 23(5):509-514.

18. Kahan RS, Perez-Figaredo RA, Neimanis A. Necrolytic migratory erythema. Distinctive dermatosis of the glucagonoma syndrome. Arch Dermatol 1977; 113(6):792-797.

19. Wermers RA, Fatourechi V, Wynne AG, et al. The glucagonoma syndrome: clinical and pathologic features in 21 patients. Medicine (Baltimore) 1996; 75(2):53-63.

20. Chastain MA. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci 2001; 321(5):306-320.

0 0

Post a comment